Discover how we help companies like LabGenius pitch for biotech investment.
Helping investors understand AI-optimized immunotherapy.
The Brief
Explain "black box" AI without disclosing proprietary research.
Show superior molecule design than competition.
Visualize invisible logic to gain investor trust.
The Results
Closed £35M Series B funding round.
Featured in NVIDIA's GTC Paris Keynote 2025.
Secured CNN program coverage.
Final Product
Cinematic 3D animation bridging silicon and biology.
Fusion delivered a medical Animation that moved away from the standard "messy biology" look and adopted a clean, high-tech, aesthetic that mirrored the LabGenius brand
The animation utilized clear visual metaphors to demonstrate how their EVA platform evolves molecules to lock onto tumors with precision while bypassing healthy cells.
Details
Science made unmissable.
In this project, we had to show the hidden logic of LabGenius’ machine learning platform and EVA molecule evolution. Emphasis was needed on the critical difference between a standard antibody and a LabGenius-optimised one, highlighting how it solves the problem of off-tumour toxicity, killing cancer cells while leaving healthy tissue alone.
More Case Studies
The proof is in the pudding. Check out our previous solutions for more insight into how we can help.
